5PSQ-064 Concomitant treatment with atezolizumab and enzalutamide for metastastic non-small-cell lung cancer and metastastic prostate cancer: a case report

Autor: A Melgarejo-Ortuño, MP Bautista-Sanz, A Sánchez-de-Torre, E Bernal-Hertfelder, CA Apezteguia-Fernández, C de-Cáceres-Velasco, MÁ Amor-García, E Matilla-Garcia, B Rodríguez-Vargas, R Moreno-Diaz

Publikováno v: Section 5: Patient safety and quality assurance.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8257b19af2489d706c0071dbc2b46fd7
https://doi.org/10.1136/ejhpharm-2023-eahp.279

4CPS-091 What you need to know about brugada syndrome if you are a hospital pharmacist

Autor: R Moreno Diaz, A Melgarejo Ortuño, MA Amor García, C de Cáceres Velasco, E Matilla Garcia, MP Bautista Sanz

Publikováno v: Section 4: Clinical pharmacy services.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0e2bf7ebd56e37618da033604ada3e1b
https://doi.org/10.1136/ejhpharm-2023-eahp.111

What about cardiovascular toxicities of immune checkpoint inhibitors?

Autor: Moreno Diaz R; Pharmacy Department, Hospital Universitario Infanta Cristina, Parla, Spain rmorenod@salud.madrid.org., Cazalla Garcia M; Pharmacy Department, Hospital Universitario Infanta Cristina, Parla, Spain., Bautista Sanz MP; Pharmacy Department, Hospital Universitario Infanta Cristina, Parla, Spain., Gonzalez Davia R; Cardiology, Hospital Universitario Infanta Cristina, Parla, Spain., Rosero Rodriguez AC; Oncology, Hospital Universitario Infanta Cristina, Parla, Spain.

Publikováno v: European journal of hospital pharmacy : science and practice [Eur J Hosp Pharm] 2021 Jan; Vol. 28 (1), pp. 2-3. Date of Electronic Publication: 2020 Apr 23.